Ivester Priscilla, Shively Carol A, Register Thomas C, Grant Kathleen A, Reboussin David M, Cunningham Carol C
Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1016, USA.
Alcohol Clin Exp Res. 2003 Nov;27(11):1831-7. doi: 10.1097/01.ALC.0000095633.26284.FA.
Although evidence has accumulated for the cardioprotective effects of moderate ethanol consumption, little is known about the effects on the liver of consuming the equivalent of two drinks per day. The objective of this study was to determine the effects of moderate ethanol administration on the hepatic content of enzymes involved in ethanol oxidation, on hepatic lipid accumulation, and on serum markers of liver function/damage in the monkey, Macaca fascicularis.
Ovariectomized, adult monkeys were maintained for 34 months on an atherogenic diet containing cholesterol 1.21 mg/kJ. They were trained to drink ethanol plus vehicle at a dose of 0.5 g/kg body weight, which was administered 5 days a week for 2 years. Blood was collected for ethanol concentrations (1 hr after ethanol administration) and was also assayed for gamma-glutamyltransferase, alanine aminotransferase (ALT), and alkaline phosphatase (ALP) activities. Liver obtained at necropsy was analyzed for triglyceride and cholesterol contents and for alcohol dehydrogenase, cytochrome P450 2E1, and cytochrome P450 3A4 by Western blots.
The blood ethanol concentrations measured 1 hr after ethanol administration were relatively constant over the 2-year dosing period. Hepatic levels of alcohol dehydrogenase and the cytochrome P450s were not significantly different between ethanol-consuming animals and control animals. Ethanol-associated increases in liver triglyceride were not significant due to high variability in hepatic lipid content in both the controls and ethanol consumers. However, covariance analyses using pretreatment concentrations of plasma cholesterol and apolipoprotein A-I suggested that the ethanol-related increase in hepatic free cholesterol was significant. Relative to controls, alcohol consumers had higher levels of serum ALT and a transient increase in ALP at 5 months.
The observations made in this study on primates administered an atherogenic diet suggest that moderate ethanol ingestion has modest effects on the liver, including slightly increased ALT and ALP values. However, additional studies will be required to verify that this level of consumption is hepatotoxic when ingested over extended periods. This is still a concern because some human studies suggest that levels of ethanol considered to be cardioprotective cause liver injury when consumed over a lifetime.
尽管已有证据表明适度饮酒具有心脏保护作用,但对于每天饮用相当于两杯酒的量对肝脏的影响却知之甚少。本研究的目的是确定适度给予乙醇对食蟹猴肝脏中参与乙醇氧化的酶含量、肝脏脂质蓄积以及肝功能/损伤血清标志物的影响。
将成年去卵巢猴子维持在含有1.21 mg/kJ胆固醇的致动脉粥样化饮食中34个月。训练它们饮用乙醇加赋形剂,剂量为0.5 g/kg体重,每周给药5天,持续2年。采集血液检测乙醇浓度(乙醇给药后1小时),并检测γ-谷氨酰转移酶、丙氨酸氨基转移酶(ALT)和碱性磷酸酶(ALP)活性。对尸检时获得的肝脏进行甘油三酯和胆固醇含量分析,并通过蛋白质免疫印迹法检测乙醇脱氢酶、细胞色素P450 2E1和细胞色素P450 3A4。
在2年的给药期内,乙醇给药后1小时测得的血液乙醇浓度相对恒定。饮酒动物和对照动物肝脏中的乙醇脱氢酶和细胞色素P450水平无显著差异。由于对照组和饮酒组肝脏脂质含量的高变异性,乙醇相关的肝脏甘油三酯增加不显著。然而,使用血浆胆固醇和载脂蛋白A-I的预处理浓度进行的协方差分析表明,乙醇相关的肝脏游离胆固醇增加是显著的。与对照组相比,饮酒者血清ALT水平较高,且在5个月时ALP有短暂升高。
本研究对给予致动脉粥样化饮食的灵长类动物的观察表明,适度摄入乙醇对肝脏有适度影响,包括ALT和ALP值略有升高。然而,需要进一步研究来验证长期摄入这种水平的乙醇是否具有肝毒性。这仍然是一个令人担忧的问题,因为一些人体研究表明,被认为具有心脏保护作用的乙醇水平在一生饮用过程中会导致肝损伤。